XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES

SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Combined Mark

XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES

Key Information

Serial Number

86522594

Registration Number

4942590

Status

Section 8 & 15-accepted and Acknowledged

Ownership

Owner Name

Astellas US LLC

Type: Organization / Limited Liability Company

Address

2375 Waterview Drive

Northbrook, IL 60062

Critical Dates

First Use Date

Aug 1, 2014

Filing Date

Feb 3, 2015

Registration Date

Apr 19, 2016

Mark Descriptions

Services

Class 41

Providing educational services, namely, conducting classes, seminars, webinars, workshops, and speaker programs to patients and healthcare providers in connection with prostate cancer access and reimbursement programs; "SUPPORT SOLUTIONS ENZALUTAMIDE 40 MG CAPSULES"

Mark Elements

Text Mark

XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES

Trademark Timeline

First Use

Aug 1, 2014

Filing Date

Feb 3, 2015

Publication Date

Aug 4, 2015

Registration Date

Apr 19, 2016

USPTO Records

No documents found for this trademark.

Never miss important updates for XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach